Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Operating Expenses: 2019-2021

Historic Operating Expenses for Bright Minds Biosciences (DRUG) over the last 3 years, with Sep 2021 value amounting to $5.2 million.

  • Bright Minds Biosciences' Operating Expenses rose 2485.36% to $1.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2021, which is 4176.18% up from last year.
  • Per Bright Minds Biosciences' latest filing, its Operating Expenses stood at $5.2 million for FY2021, which was up 4,176.18% from $120,477 recorded in FY2020.
  • In the past 5 years, Bright Minds Biosciences' Operating Expenses ranged from a high of $5.2 million in FY2021 and a low of $31,827 during FY2019.
  • For the 3-year period, Bright Minds Biosciences' Operating Expenses averaged around $1.8 million, with its median value being $120,477 (2020).
  • Data for Bright Minds Biosciences' Operating Expenses shows a peak YoY soared of 4,176.18% (in 2021) over the last 5 years.
  • Bright Minds Biosciences' Operating Expenses (Yearly) stood at $31,827 in 2019, then soared by 278.53% to $120,477 in 2020, then spiked by 4,176.18% to $5.2 million in 2021.